India
At current valuations, investors are not just buying hospitals. They are buying a growth story.
1
Secondaries part of broader capital solutions offering, not standalone: Temasek
2
What Danantara is really buying with its $2.5b JBS bet
3
From coffee to hotpot, brands race to grab a bite of China's growing burger market
4
SG's Medi Lifestyle agrees to buy 60% stake in Q & M Dental's AI platform
5
Nvidia eyes investing $3b in SB Energy under OpenAI data centre deal
More Stories
Editor’s take: The week that was — Aug 10-15
V3 Ventures leads $3m funding in Scrubsy, and other India deals
SG’s Medi Lifestyle agrees to buy 60% stake in Q & M Dental’s AI platform
Greater China
The mid-market vacuum is a clear opportunity for managers with a differentiated thesis.
HKIC has a portfolio of over 200 firms. So far, 10 have listed in HK, with 30 more in the pipeline.
Nearly one in four GPs reported reinvestment rates of 20% or less.
This edition examines macro and policy factors driving PE activity across Japan, India and China.
Capital is flowing, with a range of strategies targeting each geography.
This edition captures the liquidity playbook, diversification and capital consolidation trends in Asia.
IPO markets have been uneven, and large exits at peak valuations are getting harder to pull off.
The regulatory ground in China has shifted dramatically in the past four months.
Philippines
This private sector push is now backed by a structural shift within the bank.